Precancerous Lesion of the Cervix and Associated Factors Among Women of West Wollega,West Ethiopia,2022

Abstract

Background

Precancerous cervical lesion is an abnormality in the cells of the cervix that could eventually develop into cervical cancer. Cervical cancer is a public health problem that contributes to the death of women worldwide. In line with the high burden of the issue, the Ethiopian government had attempted to expand cervical cancer screening centers and recommendation of services to age-eligible as well as high-risk groups of women. Therefore, the study aimed to assess the prevalence of precancerous lesions of cervix cancer among women aged 30-49 years and associated factors in West Wollega.

Method

Facility-based analytic cross-sectional study design was conducted in selected hospitals of West Wollega from January 1- February 20, 2022, among 339 women. A face-to-face interview was conducted and the presence or absence of precancerous cervical lesion was tested by visual inspection with acetic acid. Data were analyzed by SPSS version 25. Variable with P-value <.25 in the bi-variable analysis were entered into multivariable logistic regression. Results with a P-value ≤ .05 at 95% confidence level were considered for statistical significance.

Result

The prevalence of precancerous cervical lesions was 27.4% (95% CI: 22.7%32.1%). The mean standard deviation of participants was 35.22 +6.32 years. More than half (63.4%) and 67.6% of them were regarded as having good knowledge and a favorable attitude towards precancerous cervical lesions respectively. History of menstrual irregularity had two folds higher odds of being diagnosed with the precancerous cervical lesion when compared with counterparts at, [AOR = 2.29(95% CI:1.29-4.04]. Women with a history of STI had 3.5 times higher odds of developing precancerous cervical lesion compared to women with no history of STI [AOR)=3.46(95% CI:1.94-6.18)], history of bleeding after sexual intercourse was 2.88 times more likely to have precancerous cervical lesion compared to those without it at [AOR=2.88(95% CI:1.43-5.78)]. Parity greater than or equal to five had 2.4 times higher odds of developing precancerous cervical lesions compared to women with parity less than five at [AOR=2.41(95% CI: 1.23-4.75)]. History of steroid use had 3.5 times higher odds of developing precancerous cervical lesion compared with opponents at [AOR=3.5(95% CI: 1.32-9.34) and women with an Unfavorable attitude towards screening for Cervical cancer screening, prevention, and control methods had 2.2 times higher odds of developing precancerous cervical lesion compared their counterpart at [AOR=2.15(95% CI: 1.21-3.83)].

Conclusion

The precancerous cervical lesions continue to be a significant public health concern in Ethiopia. It will remain a significant cause of death of women unless effective screening methods like VIA and vaccination against HPV are scaled up. Furthermore, having a history of menstrual irregularities, STI, bleeding after coitus, parity greater than ≥5, steroid use, and having an unfavorable attitude towards screening factors are significantly associated with the occurrence of the precancerous lesion. Therefore, effective prevention approaches have to consider these factors for the control of cervical cancer in the early phase of the lesion.

Keywords

cervical cancer knowledge attitude and visual inspection with acetic acid

Introduction

A precancerous cervical lesion, which is also called an intraepithelial lesion, is an abnormality in the cells of the cervix that could eventually develop into cervical cancer.¹ Cervical cancer is a crucial point of action for any cancer control program because of the burden of the disease, and the possibilities for effective prevention via screening.² It is historically classified as adenocarcinoma and squamous cell carcinoma in 99% of women with squamous cervical carcinoma caused by Humans Papillomavirus (HPV) infection.³

Cervical cancer is the leading cause of death in women. Worldwide, cervical cancer is the fourth leading cause of death in women.⁴ By 2020, an estimated 604000 women have been diagnosed with cervical cancer worldwide and an estimated 342,000 women have died of the disease.³ Globally, cervical cancer has an occurrence rate of 371,000 cases and a death rate of 190,000 with 80% of the cancer of the cervix death occurring in resource-limited countries. The maximum rates are found in Central and South America, East Africa, South, and South-East Asia, and the Western Pacific. The problem is mainly worse in sub-Saharan Africa.¹ In Africa, 80,400 women were diagnosed with cervical cancer each year and it is the second most common cancer in the region. Furthermore, 50,300 women die each year from the disease and it is the leading cause of death from cancer. In sub-Saharan Africa, cervical cancer accounts for 22.5% of all women with cancer, and the majority of women with cervical cancer live in rural areas.^5,6 Ethiopia ranked 14th led by Malawi among the East African Countries. In Ethiopia, about 7095 new cervical cancer cases are diagnosed annually which makes it the 2nd leading cause of female cancer and the 2nd most common female cancer in women aged 15-44 years according to an estimate 2012.^7,8

According to World Health Organization (WHO) estimates, cervical cancer is expected to kill more than 443,000 women by 2030, with a high rate (over 98% of deaths) believed to occur in developing countries (especially in Sub-Saharan Africa (SSA).⁹ Non-communicable diseases such as cervical cancer cause devastating effects in developing countries.⁵ Cervical cancer is the most common cancer in 23 countries and is the leading cause of death in 36 countries. Most of these countries are in sub-Saharan Africa, Melanesia, South America, and Southeast Asia.¹⁰ Precancerous lesions can be progressed to cervical cancer and the risk for the development of cervical cancer if there is missed the chance of early identification of the precancerous lesion and its risk factor.¹¹ It can be prevented, unlike other reproductive cancers through effective screening programs.¹² According to an estimate in 2012, there were about 4732 cervical cancer deaths which occurred annually making cervical cancer the 2nd leading cause of female cancer deaths in Ethiopia. As well as being the 2nd leading cause of cancer mortality in women aged 15-44 years. This implies there will excessive life loss due to the disease unless prompt intervention like screening and vaccination is undertaken.⁸ Early screening and vaccination are some prevention strategies for cervical cancer. However, the risk of death from complications related to cancer of the cervix may be mainly affiliated to health problems over the course of a woman’s life in low income countries.¹³ Vaccination can be viewed as primary prevention, with screening as secondary prevention.¹²

Even though the cause for many cancers remains unknown, established cancer causes include external factors like lifestyle, such as tobacco use and excess body weight, and non-modifiable judged as internal factors, including inherited genetic mutations, hormones, and immune conditions are contributors.¹⁴ The peak age of incidence was between 40 and 49 years. Most of the cases were found in Addis Ababa, where the hospital is situated. An increase in the trend of cervical cancer cases was observed.² In addition, in Ethiopia, early sexual activity, high HIV prevalence, and low socioeconomic status may place women at risk for cervical cancer.¹⁵

It is estimated that about 1-2% of women have CIN2 + each year. This rate is reported to be higher for HIV-positive women, at 10%.^1-5,16 In high-income countries, regular Pap smear tests have been shown to reduce the risk of developing cervical cancer, by detecting malignant mutations.¹⁷ As the problem is escalating in low and mid-income countries, interventions like using visual inspection with acetic acid has been revealed to be effective for screening in precancerous lesion low resource settings.¹⁸

Cervical cancer is preventable, however many women in low-income countries do not have access to effective screening programs. Ethiopia has no standard policy or protocol for cervical cancer screening, rather it is patchy or inconsistent. Ethiopian women typically present for cancer care at a late stage in the disease, where treatment is likely ineffective.¹⁹There are no specific symptoms and no clinical features indicating the presence of a CIN. Many of these lesions, however, may become white when 3-5% acetic acid is added and possibly iodine-negative in the use of Lugol’s iodine solution, as the CIN epithelium contains little or no glycogen.²⁰ Like that of colorectal cancer screening, this procedure can help to prevent cervical cancers by giving opportunity for early identification and removal of precancerous lesions. It also provides the chance to identify as early as possible, when treatment is less extensive and more likely to be successful. Furthermore, screening is known to contribute in decrement of death from cancers including cervical cancer.¹⁴ However, lack of funding for diagnostic services, low awareness of testing, and lack of trained health professionals are also major challenges in diagnosing and treating cervical cancer.²¹

Reducing the magnitude and tackling the factors related with precancerous lesion is very important. As it is very crucial to produce significant decreases in incidence and mortality from precancerous lesion, barriers should be identified. Therefore, this study is aimed at determining the magnitude of this lesion within the study area and factors contributing to the problem.²² Every woman has the right to be screened for cervical cancer at least once in her lifetime. However, in resource-poor settings, 30–49-year-old women comprise the target audience because cervical cancer is rare in women under 30 and most common in women over 40 years. Screening younger women will detect many lesions that will never develop into cancer, will lead to considerable overtreatment, and is not cost-effective.^1,23 In the same manner, the World Health Organization set priority to be given to screening women aged 30-49 years in the general population of women.²³ In Ethiopia according to the population census of 2013 EFY/2020/21 G.C projected estimate of women aged 30-49 years comprises approximately 19.2% of the total population.¹ To the best of author’s knowledge, prevalence, and factors for precancerous cervical lesions, have not been studied yet in study area. Therefore, this study will serve for clinicians, policy makers, and program planner’s designers as a resource for the design of appropriate interventions to decrease cervical cancer in areas like vaccination, early screening, and awareness creation. Further, the results of the study may serve as baseline information for future research.

Method and Materials

Study Area, Population, Source, Design

This study was conducted in selected hospitals of West Wollega, which is found in Oromia National Regional State, located at a distance of 441 km from Addis Aba. It has a total population of 1,951,933 (Urban %13 Rural 87%). Five government hospitals, two NGO hospitals, 67 health centers, and 560 public health facilities are currently functional. Data were collected from January 1-February 20/2022. The participants were selected from all women of age 30-49 years’ living in the West Wollega zone, while all selected women of age between 30 and 49 years attending pre-cervical cancer screening at West Wollega Hospitals and selected health centers were studied by institutional-based prospective analytic cross-sectional study design was employed.

Sample Size Determination and Sampling Procedure

The sample size was calculated using a single population proportion formula; considering 27.7% as the prevalence of pre-cervical cancer among clients screened in Southern Ethiopia,³ 5% margin of error, and a 10% estimated non–response rate.Where, n = the sample size required.N= Number of householdsP = 27.7% prevalence of pre-cervical cancer among clients screened in Southern Ethiopiad = margin of sampling error tolerated Zα/2 = the standard normal variable at (α-1) or 95% confident level = 1.96

Since the total population is >10,000 no need for a correction formula:

The sample size was found to be 308. By adding a 10% non-response rate the final sample size is 339.Hospitals and health centers providing routine cervical cancer screening and treatment using VIA and cryotherapy services were purposively selected. Women aged 30-49 years in four hospitals and five selected health centers were 125,250 (Gimbi General Hospital=24,011, Gimbi Adventist Hospital=19,583, Nedjo General Hospital=22,539, and Aira General Hospital=18,474) (five selected health center =40,643. The calculated sample size was allocated using probability proportional to size (PPS) and finally convenient sampling was used to select the study subjects.

Data Collection Instruments and Procedure

Data were collected through face-to-face interviews with a structured questionnaire that was initially adapted from previous studies.⁴ The questionnaire was prepared in English, translated to Afan Oromo, and then back to English to check the consistency. Ten BSc nurses and five supervisors were assigned for data collection and supervision.

Data Quality Control

One-day orientation was given for data collectors and supervisors to ensure the quality of the field operation by principal investigators. Supervisors supervised the data collection process on daily bases and check the quality of collected data. The data collection tool was pre-tested on 5% of the sample at Arjo health center. Based on the findings and feedback obtained from the pre-testing process, a modification was made to the questionnaire.

Data Processing and Analysis

The data were entered into Epi-data version 3.2 and analyzed by SPSS version 25.0 for further analysis and interpretation. Descriptive analysis was carried out for each of the variables to check frequency, distribution, and missing values. Variable with a p-value of <.25 on bi-variable analysis were entered into a multivariable logistic regression to identify predictors of pre-cancerous lesion of the cervix. The odds ratio at 95% confidence intervals was used to quantify the degrees of association. Results with a p-value ≤.05 were considered as being statistically significant

Operational Definition and Definition of Terms

A positive VIA - as “sharp, distinct, well-defined, dense (opaque, dull, or, oyster white) acetowhite areas with or without raised margins, abutting the squamocolumnar junction in the transformation zone” or “strikingly dense acetowhite areas in the columnar.¹

Good Knowledge: Respondents who scored >the mean value of 75 from total 22 knowledge assessing questions.

Poor Knowledge: Respondents who scored ≤ the mean value of 75 from total 22 knowledge assessing questions.

Favorable Attitude: respondents who scored>than the mean value of 67 from total 12 attitude assessing questions

Unfavorable Attitude: respondents who scored ≤ than the mean value of 67 from total 12 attitude assessing questions

Ethical Consideration

Ethical Clearence letter was obtained from the West Wollega Zonal Health Department research, ethics review committee with reference number 199/WEFGL/13, Date-12/12/13, and then a formal letter was written to all Hospitals and health centers included within the study before data collection. All study participants were provided information about the study purpose and confidentiality of information. The participants were informed to withdraw participation at any point if they felt discomfort. Written informed consent was obtained from each study participant.

Results

Socio-Demographic Characteristics of the Study Participants

A total of 339 women were interviewed during the study period with a response rate of 100%. The mean (±SD) age of the respondents were35.22± 6.32. Most of the participants were married, 295(87%) in marital status and about 228(67.3%) of them were Protestant religion followers in religion. Most of them were rural in residence 215(63.4%) and the majority of them, 282 (83.2%), were unemployed in occupation. One hundred sixty-one (47.5%) of the interviewed women had health insurance. Among those interviewed, 41% of the study participants’ educational status was primary level followed by non-formal education (Table1).

Table 1.

Sociodemographic Characteristics of Study Participants, West Wollega, Ethiopia, 2022.

Variable(n = 339)	Variable categories	Frequency	Percent
Age of respondents	15-34	140	41.3
Age of respondents	35-54	199	58.7
Marital status	Married	295	87.0
	Single	6	1.8
	Divorced	14	4.1
	Widowed	24	7.1
Religion	Protestant	228	67.3
	Orthodox	65	19.2
	Adventist	13	3.8
	Muslim	33	9.7
Ethnicity	Oromo	320	94.4
	Amhara	16	4.7
	Others	3	0.9
Residence	Urban	215	63.4
Residence	Rural	124	36.6
Occupational status	Employed	57	16.8
Occupational status	Unemployed	282	83.2
Educational status	No formal education	93	27.4
	Primary level	139	41
	Secondary level	61	18
	College and above	46	13.6
Member of health insurance	Yes	161	47.5
Member of health insurance	No	178	52.5
Monthly income (in ETB)	0-600	253	74.6
Monthly income (in ETB)	601-12000	86	25.4

Obstetrics and Gynecological History

Of the total study participants, 323(95.3%) had pregnant history and 317(93.5%) had given birth in their life. The mean age at first birth of the respondents with SD was 19.73 +2.58. Ninety-nine (29.2%) of the study participants reported they have experienced at least one episode of abortion and 132(38.9%) had a history of the irregular menstrual cycle. Forty-four (13%) of the study participants reported as they have a history of multiple sexual partners and 127(37.5%) had a history of STI. Around thirty-five percent of the study participants had been sero-positive for HIV. Regarding family history, the precancerous cervical lesion was diagnosed in 36(10.6%) of the study participant’s family members. Almost thirty-one percent of the interviewed study participants utilized OCP as a method of family planning (Table 2).

Table 2.

Obstetrics and Gynecological Related History of Study Participants, West Wollega, Oromia, Ethiopia, 2022.

Variable(n = 339)	Variable categories	Frequency	Percent
Ever became pregnant	Yes	323	95.3
Ever became pregnant	No	16	4.7
Ever given birth	Yes	317	93.5
Ever given birth	No	22	6.5
Age at first intercourse	<18 yrs	97	28.6
Age at first intercourse	≥18 yrs	242	71.4
Age at first birth	15-18	104	32.8
Age at first birth	19-49	213	67.2
Number of pregnancies	0-4	262	77.3
Number of pregnancies	5-10	77	22.7
Number of deliveries	0-4	268	79.1
Number of deliveries	5-10	71	20.9
History of abortion	Present	99	29.2
History of abortion	Not present	240	70.8
Menstrual cycle	Regular	207	61.1
Menstrual cycle	Irregular	132	38.9
History of bleeding after sexual intercourse	Present	59	17.4
History of bleeding after sexual intercourse	Not present	280	82.6
History of multiple sexual partners	Present	44	13.0
History of multiple sexual partners	Not present	295	87.0
History of STI	Present	127	37.5
History of STI	Not present	212	62.5
Family diagnosed with precancerous cervical lesion?	Yes	36	10.6
Family diagnosed with precancerous cervical lesion?	No	303	89.4
History of cigarette smoking	Present	1	.3
History of cigarette smoking	Not present	338	99.7
History of Alcohol Consumption	Present	18	5.3
History of Alcohol Consumption	Not present	321	94.7
History of chronic steroid use	Present	26	7.7
History of chronic steroid use	Not present	313	92.3
HIV status	Positive	117	34.5
HIV status	Negative	222	65.5
Family planning use	OCP	104	30.7
	Injectable	189	55.8
	Implant	113	33.3
	IUCD	30	8.8

Knowledge of Precancerous Cervical Lesion Risks, Signs, Prevention, and Consequence

Among the study participants interviewed, only 217 (64%) had ever heard about precancerous cervical lesions of which 56.6% replied media is a source of their information, and 75(34.2%) reported health care workers. Around three fourth (77.3%) claimed as having multiple sexual partners as a risk for precancerous cervical lesions. Early sexual practice (<18 years) and cigarette smoking as risk factors for precancerous cervical lesions were reported by 67% and 60.8% of respondents, respectively. In general, 215(63.4%) of the study participants were regarded as having good knowledge of precancerous cervical lesions Table 3.

Table 3.

Knowledge Status of Respondents Regarding Precancerous Cervical Lesion, West Wollega, 2022.

Variable(n = 339)	Variable categories	Frequency	Percent
Heard about precancerous cervical lesions?	No	122	36.0
Heard about precancerous cervical lesions?	Yes	217	64.0
Source of information	Media	124	56.6
	Health workers	75	34.2
	Family	6	2.7
	Neighbors/Community	12	5.5
HPV infection is a risk for precancerous cervical lesions?	No	188	55.5
HPV infection is a risk for precancerous cervical lesions?	Yes	151	44.5
Having multiple sexual partners is a risk for precancerous cervical lesions?	No	77	22.7
	Yes	262	77.3
Performing early sexual practice <18 years is a risk for precancerous cervical lesion?	No	112	33.0
	Yes	227	67.0
Use of contraceptive for >6 years is a risk for precancerous cervical lesion?	No	200	59.0
	Yes	139	41.0
Does cigarette smoking expose precancerous cervical lesions?	No	133	39.2
	Yes	206	60.8
Do precancerous cervical lesion symptoms gradually appear?	No	98	28.9
Do precancerous cervical lesion symptoms gradually appear?	Yes	241	71.1
Abnormal vaginal bleeding is a sign of precancerous cervical lesion?	No	76	22.4
	Yes	263	77.6
Bleeding or pain after coitus is a sign of precancerous cervical lesion?	No	81	23.9
	Yes	258	76.1
CC screening used to prevent precancerous cervical lesions?	No	52	15.3
CC screening used to prevent precancerous cervical lesions?	Yes	287	84.7
The HPV vaccine is used to prevent precancerous cervical lesions?	No	122	36.0
	Yes	217	64.0
Women with untreated precancerous cervical lesions can die?	No	26	7.7
Women with untreated precancerous cervical lesions can die?	Yes	313	92.3
Advanced stage of precancerous cervical lesion causes infertility?	No	47	13.9
	Yes	292	86.1
Does the precancerous cervical lesion cause reproductive organ disability?	No	25	7.4
	Yes	314	92.6
The advanced stage of CC causes psychosocial problems in women’s life?	No	34	10.0
	Yes	305	90.0
The precancerous cervical lesion is easily cured if detected at an early stage?	No	41	12.1
	Yes	298	87.9
Are women aged 30-49 recommended to take the precancerous cervical lesion screening?	No	45	13.3
	Yes	294	86.7
Overall, knowledge level (good knowledge)	Yes	215	63.4
Overall, knowledge level (good knowledge)	No	124	36.6

Level of Attitude

Among the study participants, 145(42.8%), 143(42.2%), and 157(46.3%) had strongly agreed that cancer of the cervix is highly prevalent in Ethiopia, precancerous cervical lesion affects any woman, and precancerous cervical lesion can be prevented, respectively. Almost 50% of the study participants strongly agreed that having precancerous cervical lesion screening is not harmful and that the service is given free of charge. In general, 229(67.6%) of the respondents had a favorable attitude toward pre-cancerous cervical lesion screening, prevention, and control methods (Table 4).

Table 4.

Attitude Level of the Study Participants, West Wollega, 2022.

Variables	Strongly disagree (#/%)	Disagree (#/%)	Neutral (#/%)	Agree (#/%)	Strongly agree (#/%)
Cancer of the cervix is highly prevalent in Ethiopia	33(9.7)	12(3.5)	58(17.1)	91(26.8)	145(42.8)
Precancerous cervical lesion affects any women	20(5.9)	22(6.5)	64(18.9)	90(26.5)	143(42.2)
Any adult woman including you can acquire precancerous cervical lesion	14(4.1)	37(10.9)	45(13.3)	77(22.7)	166(49)
Cancer of the cervix cannot be transmitted	58(17.1)	34(10)	90(26.5)	62(18.3)	95(28)
The precancerous cervical lesions can be prevented	21(6.2)	16(4.7)	57(16.8)	88(26)	157(46.3)
Having precancerous cervical lesion screening has no harm	18(5.3)	18(5.3)	43(12.7)	84(24.8)	176(51.9)
Precancerous cervical lesion screening is free of charge	17(5)	17(5)	40(11.8)	81(23.9)	184(54.3)
You should recommend your friends be screened	11(3.2)	12(3.5)	45(13.3)	88(26)	183(54)
The precancerous cervical lesion is fatal	14(4.1)	12(3.5)	53(15.6)	67(19.8)	193(56.9)
Your husband allows and supports you to be screened for precancerous cervical lesion	8(2.4)	16(4.7)	80(23.6)	90(26.5)	145(42.8)
You should personally support precancerous cervical lesion patients	9(2.7)	18(5.3)	52(15.3)	76(22.4)	184(54.3)
The overall level of attitude	Frequency		Percent
Favorable attitude	229		67.6
Unfavorable attitude	110		32.4

Prevalence of Precancerous Cervical Lesion Among Study Participants

Visual Inspection of Acetic Acid was made to identify presence of cervical lesion. Accordingly, 27.4% of the were judged as having cervical lesion (positive for the test) at time of data collection. Accordingly, overall precancerous cervical lesions in the study area was 93 (27.4%) with (95% CI: 22.7%-32.1%).

Table 5.

Crude and Adjusted Odds Ratios of Factors Associated with the Precancerous Cervical Lesion, West Wollega, Ethiopia, 2022.

Variables (n = 339)	Categories	Precancerous cervical lesion (VIA) results				OR (95% CI)
Variables (n = 339)	Categories	Negative	Positive	Crude OR	P-value	Adjusted OR	P-value
Menstrual cycle	Regular	168(81.1%)	39(18.9%)		.001^a	2.29(1.29-4.04)	.004^a
Menstrual cycle	Irregular	78(59.1%)	54(40.1%)	2.98(1.82-4.89) 1	.001^a	2.29(1.29-4.04)	.004^a
Family Hx of dx for cx ca	No	225(74.3%)	78(25.7%)	2.06(1.01-4.19)	.046	1.65(.69-3.93)	.257
Family Hx of dx for cx ca	Yes	21(58.3%)	15(41.7%)	1	.046	1.65(.69-3.93)	.257
History of STI	No	177(83.5%)	35(16.5%)	1	<.001	3.46(1.94-6.18)	<.001^a
History of STI	Yes	69(54.3%)	58(45.7%)	4.25(2.57-7.03)	<.001	3.46(1.94-6.18)	<.001^a
Bleeding after intercourse	Yes	220(78.6%)	60(21.4%)	4.65(2.59-8.34)	<.001	2.88(1.43-5.78)	.003^a
Bleeding after intercourse	No	26(44.1%)	33(55.9%)	1	<.001	2.88(1.43-5.78)	.003^a
Number of pregnancies	≤4	199(76%)	63(24%)	1	.015	.47(.10-2.25)	.347
Number of pregnancies	≥5	47(61%)	30(39%)	2.01(1.18-3.46)	.015	.47(.10-2.25)	.347
Parity	0-4	196(76%)	62(24%)	1	.003	2.41(1.23-4.75)	.011^a
Parity	5-10	35(53%)	31(47%)	2.8(1.37-4.35)	.003	2.41(1.23-4.75)	.011^a
Attitude	Favorable attitude towards screening for cervical cancer	180(78.6%)	49(21.4%)	1	<.001	2.15(1.21-3.83)	.009^a
Attitude	Unfavorable attitude towards screening for cervical cancer	66(60%)	44(40%)	2.45(1.49-4.02)	<.001	2.15(1.21-3.83)	.009^a
Use of steroids	No	234(74.8%)	79(25.2%)	1	.003	3.5(1.32-9.34)	.012^a
Use of steroids	Yes	12(46.2%)	14(53.8%)	3.46(1.54-7.79)	.003	3.5(1.32-9.34)	.012^a

1=Reference

^aStatically significant

Factors associated with precancerous cervical lesion

In multivariable analysis, participants with a diagnosis of menstrual irregularity had a two folds higher odds of being diagnosed with the precancerous cervical lesion when compared with counterpart at, [AOR=2.29(95%CI:1.29-4.04]. Women with history of STI had 3.5 times higher odds of developing precancerous cervical lesion compared to women with no history of STI [AOR)=3.46(95%CI:1.94-6.18)]., Women having bleeding after sexual intercourse were 2.88 times more likely to have precancerous cervical lesion compared to those without it at [AOR=2.88(95%CI:1.43-5.78)]. Women with parity greater than or equal to five had 2.4 times higher odds of developing precancerous cervical lesions compared to women with parity less than five at [AOR=2.41(95%CI:1.23-4.75)]. Participants who had a history of steroid use had 3.5 times higher odds of developing precancerous cervical lesion compared to participants with no history of steroids use at [AOR=3.5(95%CI:1.32-9.34) and women with an unfavorable attitude towards screening for cervical cancer screening, prevention, and control methods had 2.2 times higher odds of developing precancerous cervical lesion compared to women with favorable attitude towards screening, prevention, and control methods [AOR=2.15(95%CI:1.21-3.83)] (Table 5).

Discussion

The findings of this study are in line with the results of a study from the city of Arba Minch and the Zuria region (27.7%) and are higher than those reported in Easter Ethiopia, Harar (18.5%), three referral hospitals of Amhara region 20.2%, and Jimma (12.9%).^3,5,10,13 Furthermore, the findings were significantly higher than systematic reviews conducted in Ethiopia,²⁴ Southern Ethiopia 22%,^25-26 Dessie 6.9%, Waldia and Dessie 9.9%,²⁷ Almeda textile factory in North Ethiopia 6.7%²⁸ and Rwanda.¹⁸ This reveals that the findings recommend raising of a screening strategy for cervical intraepithelial neoplasia for all women.¹³

In this study, 63.4% of study participants were well-informed about cervical cancer. The findings were higher than the study results in Butajira and Wolita of Ethiopia. On the other hand, the study also revealed that 67.6% of women interviewed had a positive attitude toward cervical smear screening under the results reported in Bishoftu town.^16,17,29

Participants with a diagnosis of menstrual irregularity had a statistically significant higher odds of association [AOR=2.29(95%CI: 1.29-4.04] for being diagnosed with a precancerous cervical lesion of the cervix, which is in line with research done in Debre -Berhan University.²² This might be a reason of other causes of abnormal menstruation including uterine cancer or cervical cancer.²⁰ As well, sometimes cervical cancer mimics menstrual bleeding. The patient may notice a longer or heavier menstrual cycle than usual or spotting or bleeding between periods²⁴

Women having STI had 3.5 times higher odds of developing precancerous cervical lesions compared to women with no history of STI [AOR) = 3.46(95%CI:1.94-6.18)], which is similar to research conducted in the Debre Markos town,³⁰ Southern Ethiopia,²⁵ and three referral hospital in Amhara region.⁵ This association might be due to that the fact that cervical cancer occurs in the cervix, which is the entrance to the uterus. More than 90% of cervical cancers develop due to persistent infection of the human papillomavirus (HPV), which is most often transmitted through sexual intercourse.²¹ It is clear that STI are a result of having sexual partners. In another way, having multiple sexual partners escalates the risk of getting HPV, and in turn, can lead to the development of cervical pre-cancer lesions.¹³ As well, it is clear that nearly all cases of cervical cancer result from infection with HPV, and the prevention of cervical cancer includes screening and vaccination.¹²

Women having a history of bleeding after sexual intercourse were more likely to have precancerous cervical lesions [AOR=2.88(95%CI: 1.43-5.78)] compared to their counterparts. This is in line with a study in Beijing.³¹ Bleeding during or after sex can be alarming, especially if the mothers were not menstruating.³² The most likely causes include a sexually transmitted infection, benign polyps, cervical ectropion, atrophic vaginitis, endometriosis, trauma, and cancer.³³ The results suggest that to prevent precancerous cervical lesions one must consider changes of lifestyle and sexual behavior.³⁴

Women with parity greater than or equal to five had 2.4 times higher odds of developing precancerous cervical lesion compared to women with parity less than five [AOR=2.41(95%CI: 1.23-4.75)], which is in line with Johannesburg South Africa,³⁵ this might be due to that high parity increases the risk of squamous-cell carcinoma of the cervix among HPV-positive women. A general decline in parity might therefore partly explain the reduction in cervical cancer recently seen in most countries.³⁶

Women with an unfavorable attitude had 2.2 times higher odds of developing precancerous cervical lesions compared to women with a favorable attitude [AOR=2.15(95%CI:1.21-3.83)]. This is in line with research done in Hawassa town³⁶ and an overall score of attitudes was 67.6%. This finding was lower than research conducted among Adama Science and Technology University Female Students which was (71.7%). This discrepancy might be due to the fact that the study area was urban and also might be due to the educational status of study participants.³⁷

Conclusions and Recommendations

Precancerous cervical lesions continue to be a significant public health concern in Ethiopia. It will remain a cause of death of women unless effective screening methods like VIA and vaccination to HPV are scaled up. Furthermore, having history of menstrual irregularities, STI, bleeding after coitus, parity greater ≥5, steroid use, and having unfavorable attitude towards screening factors are significantly associated with occurrence of precancerous lesion. This implies that clinicians can play a pivotal role in the prevention of advancement of the lesion to cancer as majority of the factors can be identified during early. Therefore, effective prevention approaches have to consider these factors for the control of cervical cancer in early phase of lesions.

List of Abbreviations/Acronyms

ASIR-Age-Standardized Incidence Rate, CIN 2 and CIN 3_Cervical Intraepithelial Neoplasia, CC- Cervical Cancer, DNA –Deoxyribose Nucleic Acid, DALYs -Disability-Adjusted Life-Years, WHO-World Health Organization, HIV- Human Immune-Virus, LSES-Low Socioeconomic Status, OR-Odd Ratio, SSA-Sub-Saharan Africa, STI-Sexually Transmitted Infection, STD-Sexually Transmitted Diseases, NGO- Non-Governmental Organization, HPV-Human Papilloma Virus, VIA- Visual Inspection with Acetic acid

Footnotes

Acknowledgments

We thank the data collectors and study participants.

Author’s contributions

KE and GF have been involved in the conception, writing the study protocol, formulating of the study design, and have provided training for data collectors, data entry, analysis, and interpretation of data. KE, MT, and LM participated in the design, interpretation of data, reviewing of intellectual content; supervising the overall process of the process, and manuscript preparation and they have provided important comments to supervise the overall process and review the manuscript. All authors have reviewed and approved this article’s final manuscript.

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the West Wollega Zone Health Office funded this studys data collection However the funder’s have no role designing study, analyzing and publishing this work.

Ethical Approval

Ethical Clarence letter was obtained from the West Wollega Zonal Health Department research, ethics review committee with reference number 199/WEFGL/13, Date-12/12/13, and then a formal letter was written to all Hospitals and health centers included within the study before data collection. All study participants were convinced a bout study purpose and confidentiality of information. The participants were informed to withdraw participation at any point they feel discomfort. Written informed consent was obtained from each study participants.

Data Availability

All the data and materials are available with the authors.

ORCID iD

Getahun Fetensa

References

FMoH . National cancer control plan 2016–2020. Addis Ababa;2015.

World Health Organization, Programme on Cancer Control (World Health Organization), World Health Organization . Reproductive health. In: Cervical cancer screening in developing countries: Report of a WHO consultation. World Health Organization;2002.

Teka

Kote

Kejela

Getachew

. Magnitude and factors associated with precervical cancer among screened women in Southern Ethiopia. Advances in Public Health. 2019;23:2019-2028.

Tekle

Wolka

Nega

Kumma

Koyira

. Knowledge, attitude and practice towards cervical cancer screening among women and associated factors in hospitals of Wolaita Zone, Southern Ethiopia. Cancer Manag Res. 2020;12:993-1005.

Deksissa

Tesfamichael

Ferede

. Prevalence and factors associated with VIA positive result among clients screened at family guidance association of Ethiopia, south west area office, Jimma model clinic, Jimma, Ethiopia 2013: A cross-sectional study. BMC Res Notes. 2015;8(1):1-6.

Zeru

Gebeyaw

Ayele

. Magnitude and associated factors of menstrual irregularity among undergraduate students of Debre Berhan University, Ethiopia. Reprod Health. 2021;18(1):1-8.

Okan

Petrova

Smith

Lesic

Bruine de Bruin

. How do women interpret the NHS information leaflet about cervical cancer screening? Med Decis Making. 2019;39(7):738-754.

Lekoane

Kuupiel

Mashamba-Thompson

Ginindza

. Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: Systematic scoping review. BMC Cancer. 2019;19(1):1.

Aweke

Ayanto

Ersado

. Knowledge, attitude and practice for cervical cancer prevention and control among women of childbearing age in Hossana Town, Hadiya zone, Southern Ethiopia: Community-based cross-sectional study. PLoS One. 2017;12(7):e0181415.

10.

Abate

. Trends of cervical cancer in Ethiopia. Cervical Cancer. 2015;1(1):1-4.

11.

Teame

Addissie

Ayele

, et al. Factors associated with cervical precancerous lesions among women screened for cervical cancer in Addis Ababa, Ethiopia: A case control study. PLoS One. 2018;13(1):e0191506.

12.

Small

Jr Bacon

Bajaj

, et al. Cervical cancer: A global health crisis. Cancer. 2017;123(13):2404-2412.

13.

Kassa

Dile

Zenebe

Berta

. Precancerous lesions of cervix among women infected with HIV in referral hospitals of amhara region, Northwest Ethiopia: A cross sectional study. Afr Health Sci. 2019;19(1):1695-1704.

14.

Society

. Cancer facts and figures. 2017.

15.

Aynalem

Anteneh

Enyew

. Utilization of cervical cancer screening and associated factors among women in Debremarkos town, Amhara region, Northwest Ethiopia: Community based cross-sectional study. PLoS One. 2020;15(4):e0231307.

16.

Kasraeian

Hessami

Vafaei

, et al. Patients’ self-reported factors influencing cervical cancer screening uptake among HIV-positive women in low-and middle-income countries: An integrative review. Gynecologic Oncology Reports. 2020;33:100596.

17.

Tekle

Wolka

Nega

Kumma

Koyira

. Knowledge, attitude and practice towards cervical cancer screening among women and associated factors in hospitals of Wolaita Zone, Southern Ethiopia. Cancer Manag Res. 2020;12:993-1005.

18.

Makuza

Nsanzimana

Muhimpundu

Pace

Ntaganira

Riedel

. Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda. Pan African Medical Journal. 2015;22(1):26.

19.

Asseffa

. Cervical cancer: Ethiopia’s outlook. J Gynecol Womens Health. 2017;5(2):555660.

20.

Varghese

Qureshi

Ronghe

Vyas

Singh

Chamarti

. Prevalence and sociodemographic covariates of cervical cancer and its association with menstrual irregularities: Findings from the 2017 national inpatient sample database. Cureus. 2021(10):13.

21.

Abebe

Eshetie

Tessema

. Prevalence of sexually transmitted infections among cervical cancer suspected women at University of gondar comprehensive specialized hospital, North-west Ethiopia. BMC Infect Dis. 2021;21(1):1-7.

22.

Desta

Getaneh

Yeserah

, et al. Cervical cancer screening utilization and predictors among eligible women in Ethiopia: A systematic review and meta-analysis. PLoS One. 2021;16(11):e0259339.

23.

World Health Organization . WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention.

24.

Tsehay

Afework

. Precancerous lesions of the cervix and its determinants among Ethiopian women: Systematic review and meta-analysis. PLoS One. 2020;15(10):e0240353.

25.

Gedefaw

Astatkie

Tessema

. The prevalence of precancerous cervical cancer lesion among HIV-infected women in southern Ethiopia: A cross-sectional study. PLoS One. 2013;8(12):e84519.

26.

Temesgen

Workie

Dilnessa

Abate

. Proportions of pre-cancerous cervical lesions and its associated factors among women clients in the age group of 30-49yrs in gynecology ward of dessie referral hospital and FGAE, North-East Ethiopia. Journal of Cancer and Tumor International. 2016;2019:1-5.

27.

Belayneh

Mitiku

Weldegebreal

. Precancerous cervical lesion and associated factors among HIV-infected women on ART in amhara regional state, ethiopia: A hospital-based cross-sectional study. Int J Health Sci. 2019;13(3):4-9.

28.

Kebede

Hailay

Teklehaymanot

. Prevalence of precancerous cervical lesion and associated factors among women in North Ethiopia. J Publ Health Epidemiol. 2017;9(3):46-50.

29.

Ruddies

Gizaw

Teka

, et al. Cervical cancer screening in rural Ethiopia: A cross-sectional knowledge, attitude and practice study. BMC Cancer. 2020;20(1):1.

30.

Wakwoya

Gemechu

. Prevalence of abnormal cervical lesions and associated factors among women in harar, eastern Ethiopia. Cancer Manag Res. 2020;12:12429-12437.

31.

Tao

Han

, et al. Prevalence and risk factors for cervical neoplasia: A cervical cancer screening program in Beijing. BMC Publ Health. 2014;14(1):1-9.

32.

Sahiledengle

Atlaw

Kumie

Tekalegn

Woldeyohannes

Agho

. Menstrual hygiene practice among adolescent girls in Ethiopia: A systematic review and meta-analysis. PLoS One. 2022;17(1):e0262295.

33.

Getahun

Addissie

Negash

Gebremichael

. Assessment of cervical cancer services and cervical cancer related knowledge of health service providers in public health facilities in Addis Ababa, Ethiopia. BMC Res Notes. 2019;12(1):1-5.

34.

Beyene

Akibu

Bekele

Seyoum

. Risk factors for precancerous cervical lesion among women screened for cervical cancer in south Ethiopia: Unmatched case-control study. PLoS One. 2021;16(7):e0254663.

35.

Assefa

Astawesegn

Eshetu

. Cervical cancer screening service utilization and associated factors among HIV positive women attending adult ART clinic in public health facilities, Hawassa town, Ethiopia: A cross-sectional study. BMC Health Serv Res. 2019;19(1):1-1.

36.

Tadesse

Tafa Segni

Demissie

. Knowledge, attitude, and practice (KAP) toward cervical cancer screening among adama science and technology university female students, Ethiopia. International Journal of Breast Cancer. 2022;13:2022-2029.

37.

Beyene

Akibu

Bekele

Seyoum

. Risk factors for precancerous cervical lesion among women screened for cervical cancer in south Ethiopia: Unmatched case-control study. PLoS One. 2021;16(7):e0254663.